Ivd Medical Holding Ltd. has announced a strategic partnership with BGI Co-Win (Shenzhen) Equity Investment Fund Management Co., Ltd. The two entities have agreed to jointly establish the IVD-BGI Co-Win Innovative Drug Intellectual Property Tokenization Fund. This initiative aims to invest in projects under Ivd Medical's NewCo + RWA Web3 Exchange Ecosystem operating model. The partnership is outlined in a framework agreement, with further details to be defined in subsequent agreements. The collaboration may proceed with projects in Hong Kong, the United States, or other overseas locations. Shareholders and potential investors are advised to exercise caution in dealing with the company's securities as the partnership plans unfold.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.